Mahmoud Aljurf - Adult Hematology/HSCT, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Ali Alsugair, Syed O. Ahmed, Mohamed Isam Sharif, Tusneem Elhassan, Hazza A. Alzahrani, Fahed Almhareb, Naeem A. Chaudhri,Fahad Alsharif,Walid Rasheed,Amr Hanbali, Feras Abdulaziz Alfraih, Marwan Shaheen,

Blood (2022): 10566-10567

引用0浏览0引用

Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation

Surbhi Sidana,Shaji Kumar,Raphael Fraser, Noel Estrada-Merly,Sergio Giralt,Vaibhav Agrawal,Larry D Anderson,Mahmoud Aljurf,Rahul Banerjee,Asad Bashey,Minoo Battiwalla,Amer Beitinjaneh,

Transplantation and Cellular Therapy（2022）

引用0浏览0WOS引用

Historical perspective and a glance into the antibody-based conditioning regimens: A new era in the horizon

Riad El Fakih,Hillard M Lazarus,Lori Muffly, Majed Altareb,Mahmoud Aljurf,Shahrukh K Hashmi

BLOOD REVIEWS（2022）

引用3浏览0WOS引用

Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia

Maria Cancio, Kyle Hebert,Soyoung Kim,Mahmoud Aljurf,Timothy Olson, Eric Anderson,Lauri Burroughs,Anant Vatsayan,Kasiani Myers,Hasan Hashem,Rabi Hanna,Biljana Horn,

Transplantation and Cellular Therapy（2022）

引用0浏览0WOS引用

Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA-Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation

Hind Alotaibi,Mahmoud Aljurf,Regis de Latour,Mansour Alfayez,Andrea Bacigalupo,Riad El Fakih,Hubert Schrezenmeier,Syed Osman Ahmed,Eliane Gluckman,Shahid Iqbal,Britta Höchsmann,Constantijn Halkes,

Transplantation and Cellular Therapy（2022）

引用0浏览0WOS引用

Early Donor T-Cell Engraftment Is Critical for Immune Tolerance in Reduced Intensity Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC2)

Jim A. Connelly, Eden Biltibo, Karina Wilkerson,Adriana Seber, Roseane V Gouveia, Carmem Bonfim,Belinda Pinto Simões,Erfan Nur, Biljana N. Horn, Michael Eckrich,Rabi Hanna, Nathalie Dhedin,

Blood (2022): 10462-10464

引用0浏览0引用

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC2)

Adetola A. Kassim, Karina Wilkerson, Josu de la Fuente,Adriana Seber, Roseane V Gouveia, Carmem Bonfim,Belinda Pinto Simões,Erfan Nur, Biljana N. Horn, Michael Eckrich,Rabi Hanna, Nathalie Dhedin,

Blood (2022): 2383-2385

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn